Cargando…

Effect of oleuropein against chemotherapy drug-induced histological changes, oxidative stress, and DNA damages in rat kidney injury

Cisplatin-based chemotherapy is responsible for a large number of renal failures, and it is still associated with high rates of mortality today. Oleuropein (OLE) presents a plethora of pharmacological beneficial properties. In this study we investigated whether OLE could provide sufficient protectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Geyikoglu, Fatime, Emir, Murat, Colak, Suat, Koc, Kubra, Turkez, Hasan, Bakir, Murat, Hosseinigouzdagani, Mirkhalil, Cerig, Salim, Keles, Osman Nuri, Ozek, Nihal Simsek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Food and Drug Administration 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332526/
https://www.ncbi.nlm.nih.gov/pubmed/28911689
http://dx.doi.org/10.1016/j.jfda.2016.07.002
_version_ 1784758669369409536
author Geyikoglu, Fatime
Emir, Murat
Colak, Suat
Koc, Kubra
Turkez, Hasan
Bakir, Murat
Hosseinigouzdagani, Mirkhalil
Cerig, Salim
Keles, Osman Nuri
Ozek, Nihal Simsek
author_facet Geyikoglu, Fatime
Emir, Murat
Colak, Suat
Koc, Kubra
Turkez, Hasan
Bakir, Murat
Hosseinigouzdagani, Mirkhalil
Cerig, Salim
Keles, Osman Nuri
Ozek, Nihal Simsek
author_sort Geyikoglu, Fatime
collection PubMed
description Cisplatin-based chemotherapy is responsible for a large number of renal failures, and it is still associated with high rates of mortality today. Oleuropein (OLE) presents a plethora of pharmacological beneficial properties. In this study we investigated whether OLE could provide sufficient protection against cisplatin-induced nephrotoxicity. With this aim, Sprague-Dawley rats were divided into eight groups: control; 7 mg/kg/d cisplatin, 50 mg/kg, 100 mg/kg, and 200 mg/kg OLE; and treatment with OLE for 3 days starting at 24 hours following cisplatin injection. After exposure to the chemotherapy agent and OLE, oxidative DNA damage was quantitated in the renal tissue of experimental animals by measuring the amount of 8-hydroxy-2′-deoxyguanosine (8-OHdG) adducts. Malondialdehyde (MDA) level, total oxidative stress (TOS), and total antioxidant status (TAS) were assessed to determine the oxidative injury in kidney cells. The histology of the kidney was examined using four different staining methods: hematoxylin-eosin (H&E), periodic acid Schiff (PAS), Masson trichrome, and amyloid. In addition, the blood urea nitrogen (BUN), uric acid (UA), and creatinine (CRE) levels were established. Our experimental data showed that tissue 8-OHdG levels were significantly higher in the cisplatin group when compared to the control group. The glomerular cells were sensitive to cisplatin as tubular cells. In addition, treatment with cisplatin elevated the levels of BUN, UA, CRE, and TOS, but lowered the level of TAS compared to the control group. The OLE therapy modulated oxidative stress in order to restore normal kidney function and reduced the formation of 8-OHdG induced by cisplatin. Furthermore, the OLE treatment significantly reduced pathological findings in renal tissue. We demonstrate for the first time that OLE presents significant cytoprotective properties against cisplatin-induced genotoxicity by restoring the antioxidant system of the renal tissue. According to our findings, OLE is a promising novel natural source for the prevention of serious kidney damage in current chemotherapies.
format Online
Article
Text
id pubmed-9332526
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Taiwan Food and Drug Administration
record_format MEDLINE/PubMed
spelling pubmed-93325262022-08-09 Effect of oleuropein against chemotherapy drug-induced histological changes, oxidative stress, and DNA damages in rat kidney injury Geyikoglu, Fatime Emir, Murat Colak, Suat Koc, Kubra Turkez, Hasan Bakir, Murat Hosseinigouzdagani, Mirkhalil Cerig, Salim Keles, Osman Nuri Ozek, Nihal Simsek J Food Drug Anal Original Article Cisplatin-based chemotherapy is responsible for a large number of renal failures, and it is still associated with high rates of mortality today. Oleuropein (OLE) presents a plethora of pharmacological beneficial properties. In this study we investigated whether OLE could provide sufficient protection against cisplatin-induced nephrotoxicity. With this aim, Sprague-Dawley rats were divided into eight groups: control; 7 mg/kg/d cisplatin, 50 mg/kg, 100 mg/kg, and 200 mg/kg OLE; and treatment with OLE for 3 days starting at 24 hours following cisplatin injection. After exposure to the chemotherapy agent and OLE, oxidative DNA damage was quantitated in the renal tissue of experimental animals by measuring the amount of 8-hydroxy-2′-deoxyguanosine (8-OHdG) adducts. Malondialdehyde (MDA) level, total oxidative stress (TOS), and total antioxidant status (TAS) were assessed to determine the oxidative injury in kidney cells. The histology of the kidney was examined using four different staining methods: hematoxylin-eosin (H&E), periodic acid Schiff (PAS), Masson trichrome, and amyloid. In addition, the blood urea nitrogen (BUN), uric acid (UA), and creatinine (CRE) levels were established. Our experimental data showed that tissue 8-OHdG levels were significantly higher in the cisplatin group when compared to the control group. The glomerular cells were sensitive to cisplatin as tubular cells. In addition, treatment with cisplatin elevated the levels of BUN, UA, CRE, and TOS, but lowered the level of TAS compared to the control group. The OLE therapy modulated oxidative stress in order to restore normal kidney function and reduced the formation of 8-OHdG induced by cisplatin. Furthermore, the OLE treatment significantly reduced pathological findings in renal tissue. We demonstrate for the first time that OLE presents significant cytoprotective properties against cisplatin-induced genotoxicity by restoring the antioxidant system of the renal tissue. According to our findings, OLE is a promising novel natural source for the prevention of serious kidney damage in current chemotherapies. Taiwan Food and Drug Administration 2016-08-02 /pmc/articles/PMC9332526/ /pubmed/28911689 http://dx.doi.org/10.1016/j.jfda.2016.07.002 Text en © 2017 Taiwan Food and Drug Administration https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Original Article
Geyikoglu, Fatime
Emir, Murat
Colak, Suat
Koc, Kubra
Turkez, Hasan
Bakir, Murat
Hosseinigouzdagani, Mirkhalil
Cerig, Salim
Keles, Osman Nuri
Ozek, Nihal Simsek
Effect of oleuropein against chemotherapy drug-induced histological changes, oxidative stress, and DNA damages in rat kidney injury
title Effect of oleuropein against chemotherapy drug-induced histological changes, oxidative stress, and DNA damages in rat kidney injury
title_full Effect of oleuropein against chemotherapy drug-induced histological changes, oxidative stress, and DNA damages in rat kidney injury
title_fullStr Effect of oleuropein against chemotherapy drug-induced histological changes, oxidative stress, and DNA damages in rat kidney injury
title_full_unstemmed Effect of oleuropein against chemotherapy drug-induced histological changes, oxidative stress, and DNA damages in rat kidney injury
title_short Effect of oleuropein against chemotherapy drug-induced histological changes, oxidative stress, and DNA damages in rat kidney injury
title_sort effect of oleuropein against chemotherapy drug-induced histological changes, oxidative stress, and dna damages in rat kidney injury
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332526/
https://www.ncbi.nlm.nih.gov/pubmed/28911689
http://dx.doi.org/10.1016/j.jfda.2016.07.002
work_keys_str_mv AT geyikoglufatime effectofoleuropeinagainstchemotherapydruginducedhistologicalchangesoxidativestressanddnadamagesinratkidneyinjury
AT emirmurat effectofoleuropeinagainstchemotherapydruginducedhistologicalchangesoxidativestressanddnadamagesinratkidneyinjury
AT colaksuat effectofoleuropeinagainstchemotherapydruginducedhistologicalchangesoxidativestressanddnadamagesinratkidneyinjury
AT kockubra effectofoleuropeinagainstchemotherapydruginducedhistologicalchangesoxidativestressanddnadamagesinratkidneyinjury
AT turkezhasan effectofoleuropeinagainstchemotherapydruginducedhistologicalchangesoxidativestressanddnadamagesinratkidneyinjury
AT bakirmurat effectofoleuropeinagainstchemotherapydruginducedhistologicalchangesoxidativestressanddnadamagesinratkidneyinjury
AT hosseinigouzdaganimirkhalil effectofoleuropeinagainstchemotherapydruginducedhistologicalchangesoxidativestressanddnadamagesinratkidneyinjury
AT cerigsalim effectofoleuropeinagainstchemotherapydruginducedhistologicalchangesoxidativestressanddnadamagesinratkidneyinjury
AT kelesosmannuri effectofoleuropeinagainstchemotherapydruginducedhistologicalchangesoxidativestressanddnadamagesinratkidneyinjury
AT ozeknihalsimsek effectofoleuropeinagainstchemotherapydruginducedhistologicalchangesoxidativestressanddnadamagesinratkidneyinjury